1.Early Detection of the Acute Exacerbation of Interstitial Pneumonia after the Surgical Resection of Lung Cancer by Planned Chest Computed Tomography.
Kunihiro OYAMA ; Masato KANZAKI ; Mitsuko KONDO ; Hideyuki MAEDA ; Kei SAKAMOTO ; Tamami ISAKA ; Jun TAMAOKI ; Takamasa ONUKI
The Korean Journal of Thoracic and Cardiovascular Surgery 2017;50(3):177-183
BACKGROUND: To improve postoperative outcomes associated with interstitial pneumonia (IP) in patients with lung cancer, the management of the postoperative a cute exacerbation of IP (PAEIP) was investigated. METHODS: Patients with primary lung cancer were considered to be at risk for PAEIP (possible PAEIP) based on a preoperative evaluation. The early phase of this study was from January 2001 to December 2008, and the late phase was from January 2009 to December 2014. In the early phase, chest computed tomography (CT) was performed for patients for whom PAEIP was suspected based on their symptoms, whereas in the late phase, chest CT was routinely performed within a few days postoperatively. The numbers of possible PAEIP cases, actual PAEIP cases, and deaths within 90 days due to PAEIP were compared between both phases. RESULTS: In the early and late phases, surgery was performed in 712 and 617 patients, 31 and 72 possible PAEIP cases were observed, nine and 12 actual PAEIP cases occurred, and the mean interval from the detection of PAEIP to starting treatment was 7.3±2.3 and 5.0±1.8 days, respectively. Five patients died in the early phase, and one patient died in the late phase. Significantly fewer PAEIP-related deaths were observed in the late phase (p<0.05). CONCLUSION: Identifying patients at risk for PAEIP by routine postoperative CT examinations led to the early diagnosis and treatment of PAEIP, resulting in the reduction of PAEIP-related mortality.
Early Diagnosis
;
Humans
;
Lung Diseases, Interstitial*
;
Lung Neoplasms*
;
Lung*
;
Mortality
;
Thorax*
;
Tomography, X-Ray Computed
2.New Diagnostic Guidelines for Idiopathic Pulmonary Fibrosis
Byoung Soo KWON ; Jin Woo SONG
Korean Journal of Medicine 2019;94(2):173-181
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung disease characterized by worsening lung function and dyspnea. The prognosis of IPF patients is poor, as median survival is approximately 3 years. However, recently developed IPF-specific therapies have shown improved efficacies in terms of reducing lung function decline and mortality. Therefore, the early recognition and accurate diagnosis of IPF are crucial. In 2018, new guidelines for the diagnosis of IPF were published by the Fleischner Society and by the American Thoracic Society/European Respiratory Society/Japanese Respiratory Society/Latin American Thoracic Society (ATS/ERS/JRS/ALAT). Both guidelines emphasize the need for a thorough history taking and physical examination to exclude an alternative diagnosis, such as exposure-related or connective tissue disease. The most informative initial examination is high-resolution computed tomography, the results of which can indicate the need for bronchoalveolar lavage or surgical lung biopsy, based on a multidisciplinary discussion of the findings and the patient's clinical condition. A multidisciplinary discussion of the clinico-radiologic-pathologic findings is currently the gold standard in the diagnoisis of IPF and will allow the more effective and timely treatment of these patients.
Biopsy
;
Bronchoalveolar Lavage
;
Connective Tissue Diseases
;
Diagnosis
;
Dyspnea
;
Humans
;
Idiopathic Pulmonary Fibrosis
;
Lung
;
Lung Diseases, Interstitial
;
Mortality
;
Physical Examination
;
Prognosis
3.Clinical Features of the 15 Patients with Idiopathic Interstitial Pneumonia.
Su Hwa PARK ; Yeon Hwa AHN ; Joung Ho HAN ; Jin Kuk KIM ; Kang Mo AHN ; Sang Il LEE
Pediatric Allergy and Respiratory Disease 2007;17(3):271-281
PURPOSE: Histologic classification plays a key role in the classification of idiopathic interstitial pneumonia (IIP) into clinically meaningful categories in terms of natural history, prognosis and treatment. The implications of histological diagnosis, clinical features and prognosis in children has not been described. This study aimed to analyze the clinical features of IIP in children. METHODS: A total of 15 patients with IIP were recruited, who had a surgical lung biopsy. The age, sex, symptoms, initial oxygen saturation, radiologic findings and clinical courses were retrospectively investigated. RESULTS: The median age at diagnosis was 3 years. Cough (93.3%), tachypnea (86.7%) and dyspnea (80%) were the most common symptoms, and laboratory findings were nonspecific. Acute interstitial pneumonia (n=6), chronic pneumonitis of infancy (n=4) nonspecific interstitial pneumonia (n=3) were relatively common. All patients received corticosteroid therapy and the mortality rate was 26.7% (n=4). CONCLUSION: IIP has diverse clinical features according to subtypes. Knowledge of the underlying histopathology will allow the prediction of more accurate prognosis, the decision of appropricate therapy, and the clinical investigation of novel therapeutic agents in patients with IIP.
Biopsy
;
Child
;
Classification
;
Cough
;
Diagnosis
;
Dyspnea
;
Humans
;
Idiopathic Interstitial Pneumonias*
;
Lung
;
Lung Diseases, Interstitial
;
Mortality
;
Natural History
;
Oxygen
;
Pneumonia
;
Prognosis
;
Retrospective Studies
;
Tachypnea
4.Thoracic Surgeon's Role in Differential Diagnosis of the Interstitial Lung Disease.
Inseok JANG ; Sung Whan KIM ; Jun Ho YAHANG ; Jong Woo KIM ; Jun Young CHOI ; Sangho RHIE
The Korean Journal of Thoracic and Cardiovascular Surgery 2006;39(5):382-386
BACKGROUND: Pathologic confirmation is needed to diagnose various forms of interstitial lung diseases. We wanted to find out how much the thoracic surgical lung biopsies will be needed for definite diagnosis of interstitial lung diseases. MATERIAL AND METHOD: 17 patients underwent surgical lung biopsy in the department of thoracic and cardiovascular surgery, Gyeongsang National University Hospital from June 1995 to November 2002. Chart review and telephone questionnaire were done for retrospective study. RESULT: Mean age was 49+/-22 years. Age ranged from 1 to 70 years. Dyspnea was the most common complaint. They were referred for definite differClinical Evaluation of Instrumental ential diagnosis from pediatrics and internal medicine. Biopsy methods were thoracotomy in 11 cases, and thoracoscopy in 6 cases. Pathologic confirmation was possible in 11 cases (65%). According to the pathologic reports, treatment plans were changed in 13 cases (76%). CONCLUSION: Surgical lung biopsy was effective method in differentiating diagnosis of the interstitial lung disease. There was no mortality during operation. It is important that undiagnosed fibrous lung disease should be recommanded the lung biopsy for planning patient's treatment.
Biopsy
;
Diagnosis
;
Diagnosis, Differential*
;
Dyspnea
;
Humans
;
Internal Medicine
;
Lung
;
Lung Diseases
;
Lung Diseases, Interstitial*
;
Mortality
;
Pediatrics
;
Surveys and Questionnaires
;
Retrospective Studies
;
Telephone
;
Thoracoscopy
;
Thoracotomy
5.Diagnosis of Interstitial Lung Disease: Comparison of HRCT, Transbronchial Lung Biopsy and Open Lung Biopsy.
Tuberculosis and Respiratory Diseases 1999;46(1):65-74
BACKGROUND: Open lung biopsy(OLB) has conventionally been regarded as the gold standard for the diagnosis in interstitial lung disease. With recent advances in diagnostic technique such as high resolution computed tomography(HRCT), and transbronchial lung biopsy(TBLB) which provide relatively accurate diagnosis of ILD, it is necessary to reevaluate the role of these methods in the diagnosis of ILD. METHODS: We carried out a retrospective analysis of nineteen patients who underwent OLB at Dankook University Hospital for the diagnosis of acute and chronic ILD, between May 1995 and June 1998. By reviewing the medical records, the demographic findings, underlying conditions, HRCT and TBLB findings, OLB diagnosis, therapy after OLB, and complication of OLB were evaluated. RESULTS: 1) Thirteen patients(68.4%) had chronic ILD(symptom duration over 2 weeks prior to OLB), and six patients(31.6%) had acute ILD(symptom duration less than 2 weeks). 2) Specific diagnosis were reached in 92%(12/13) of chronic ILD(5 Bronchiolitis obliterans organizing pneumonia(BOOP), 2 constrictive bronchiolitis, 3 Usual interstitial pneumonia, 1 hypersensitivity pneumonitis, 1 eosinophilic pneumonia), and in all patients of acute ILD(5 acute interstitial pneumonia, 1 pneumocystis carinii pneumonia). 3) HRCT were performed in all patients and a correct first choice diagnosis rate of HRCT was 42%(5/12) in chronic ILD. 4) In chronic ILD patients, 62%(8/13) received specific therapy(steroid therapy in 7 patients and moving in one patient), after OLB, but in acute ILD, all patients received specific therapy(steroid therapy in 5 patients and steroid and antibiotic therapy in one patient) after OLB. 5) The in-hospital mortality after OLB was 5.3%(1/19). CONCLUSION: OLB is an excellent diagnostic technique with relatively low complications in patients with ILD. Therefore OLB should be considered in patients with ILD when the specific diagnosis is important for the treatment, especially in patients with acute ILD.
Alveolitis, Extrinsic Allergic
;
Biopsy*
;
Bronchiolitis Obliterans
;
Diagnosis*
;
Eosinophils
;
Hospital Mortality
;
Humans
;
Idiopathic Pulmonary Fibrosis
;
Lung Diseases, Interstitial*
;
Lung*
;
Medical Records
;
Pneumocystis carinii
;
Retrospective Studies
6.Pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival.
Hong Ki MIN ; Jae Ho LEE ; Seung Min JUNG ; Jennifer LEE ; Kwi Young KANG ; Seung Ki KWOK ; Ji Hyeon JU ; Kyung Su PARK ; Sung Hwan PARK
The Korean Journal of Internal Medicine 2015;30(2):232-241
BACKGROUND/AIMS: We investigated whether transthoracic echocardiography-suspected pulmonary hypertension (PH) affects survival in systemic lupus erythematosus (SLE) patients and examined factors associated with PH occurrence and survival. METHODS: This retrospective single-center study included 154 Korean SLE patients fulfilling the American College of Rheumatology criteria (January 1995 to June 2013). Student t test, Mann-Whitney U test, Kaplan-Meier curves, and log-rank tests were used for comparisons. RESULTS: A total of 35 SLE patients with PH (SLE/PH+) and 119 without PH (SLE/PH-) were analyzed. Higher percentages of interstitial lung disease, Raynaud's phenomenon (RP), World Health Organization functional classification III/IV, and cardiomegaly were found in SLE/PH+ compared to SLE/PH-. Furthermore, the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index was significantly higher in SLE/PH+ (2.46 +/- 1.245 vs. 1.00 +/- 1.235), whereas survival rates were significantly higher in SLE/PH- in log-rank tests (p = 0.001). In multivariate analysis, the adjusted mortality hazard ratio (HR) for SLE/PH+ patients was 3.10. Subgroup analysis demonstrated a higher percentage of lupus nephritis in the SLE/PH+ patients who died (p = 0.039) and low complement-3 levels (p = 0.007). In univariate analysis, the mortality HR for SLE/PH+ patients with lupus nephritis was 4.62, whereas the presence of RP decreased the mortality risk in multivariate analysis; adjusted HR, 0.10. CONCLUSIONS: PH is an independent factor predicting survival in SLE patients. The presence of lupus nephritis resulted in an increased trend for mortality, whereas coexistence of RP was associated with a better survival prognosis in SLE/PH+ patients.
Adolescent
;
Adult
;
Cardiomegaly/diagnosis/epidemiology
;
Chi-Square Distribution
;
Female
;
Humans
;
Hypertension, Pulmonary/diagnosis/*mortality
;
Kaplan-Meier Estimate
;
Lung Diseases, Interstitial/diagnosis/mortality
;
Lupus Erythematosus, Systemic/diagnosis/*mortality
;
Lupus Nephritis/diagnosis/mortality
;
Male
;
Multivariate Analysis
;
Prognosis
;
Proportional Hazards Models
;
Raynaud Disease/diagnosis/epidemiology
;
Republic of Korea
;
Retrospective Studies
;
Risk Factors
;
Young Adult
7.HRCT Findings and Clinical Features in Non-specific and Usual Interstitial Pneumonia with Connective Tissue Diseases.
Joong Kyong AHN ; Eun Mi KOH ; You Sun LEE ; Hoon Suk CHA ; Man Pyo CHUNG ; Jungho HAN ; Dae Kun OH ; Kyung Soo LEE
The Journal of the Korean Rheumatism Association 2007;14(3):208-218
OBJECTIVE: The purpose of this study is to assess the clinical characteristics and the serial changes of high resolution CT (HRCT) findings and to correlate those with the results of clinical parameters in biopsy proven nonspecific interstitial pneumonia (NSIP) and usual interstitial pneumonia (UIP) with connective tissue diseases (CTD). METHODS: Retrospective analysis was made of forty patients with CTD diagnosed of NSIP and UIP from a single tertiary hospital between January 1996 and February 2006. RESULTS: UIP was common in rheumatoid arthritis, systemic sclerosis and Sjogren's syndrome, while NSIP was frequent in polymyositis/dermatomyositis. No significant difference was found in the clinical characteristics of patients with NSIP and UIP. In initial HRCT findings, extents of honeycombing and reticulation pattern were significantly more in UIP-CTD than in NSIP-CTD. In bronchoalveolar lavage (BAL) results, proportion of alveolar macrophages was significantly higher in NSIP-CTD than in UIP-CTD. In NSIP-CTD, significant increment in the extent of reticulation and honeycombing was noted in the serial HRCT findings despite the aggressive treatment. Significant correlation was found between leukocytosis and honeycombing change in NSIP-CTD. Despite no significant difference of survival between two groups, patients with UIP-CTD seem to have a higher mortality than those with NSIP-CTD. CONCLUSION: It is suggested that chest HRCT and BAL fluid analysis may be helpful in the differential diagnosis of NSIP- and UIP-CTD and leukocytosis in initial blood test might be predictive of honeycombing progression in NSIP-CTD. Further study will be required to compare with the prognosis of NSIP- and UIP-CTD.
Arthritis, Rheumatoid
;
Biopsy
;
Bronchoalveolar Lavage
;
Connective Tissue Diseases*
;
Connective Tissue*
;
Diagnosis, Differential
;
Hematologic Tests
;
Humans
;
Idiopathic Pulmonary Fibrosis*
;
Leukocytosis
;
Lung Diseases, Interstitial
;
Macrophages, Alveolar
;
Mortality
;
Prognosis
;
Retrospective Studies
;
Scleroderma, Systemic
;
Sjogren's Syndrome
;
Tertiary Care Centers
;
Thorax
;
Tomography, X-Ray Computed
8.Obstructive Sleep Apnea in Interstitial Lung Disease.
Shin Bum KIM ; Sang Haak LEE ; Hyeon Hui KANG
Sleep Medicine and Psychophysiology 2017;24(1):19-23
Obstructive sleep apnea is a common disorder in which respiratory flow decreases or disappears despite respiratory effort due to occlusion of the upper respiratory tract during sleep. Oxidative stress and systemic inflammatory reaction induced by the obstruction cause complications such as hypertension, coronary artery disease, and diabetes and increase cancer incidence. Furthermore, in patients with interstitial lung disease, obstructive sleep apnea has a very high prevalence and is thought to have a close pathophysiological and clinical correlation. In other words, obstructive sleep apnea could be the cause or a complication of interstitial lung disease ; when these two afflictions coexist, the prognosis of the patient is worse. In patients with interstitial lung disease with obstructive sleep apnea, CPAP treatment significantly improved sleep and quality of life, as well as improved morbidity and mortality in a recent study. Therefore, early diagnosis and treatment of obstructive sleep apnea in patients with interstitial lung disease are very important, and additional studies designed to include patients with idiopathic pulmonary fibrosis as well as patients with advanced interstitial lung disease should be performed.
Coronary Artery Disease
;
Early Diagnosis
;
Humans
;
Hypertension
;
Idiopathic Pulmonary Fibrosis
;
Incidence
;
Lung Diseases, Interstitial*
;
Mortality
;
Oxidative Stress
;
Prevalence
;
Prognosis
;
Quality of Life
;
Respiratory System
;
Sleep Apnea, Obstructive*
;
Sleep Wake Disorders
9.Mortality in patients with rheumatoid arthritis-associated interstitial lung disease treated with an anti-tumor necrosis factor agent.
Bon San KOO ; Seokchan HONG ; You Jae KIM ; Yong Gil KIM ; Chang Keun LEE ; Bin YOO
The Korean Journal of Internal Medicine 2015;30(1):104-109
BACKGROUND/AIMS: To evaluate the impact on mortality of anti-tumor necrosis factor (anti-TNF) treatment of rheumatoid arthritis-associated interstitial lung disease (RA-ILD). METHODS: We retrospectively reviewed the medical records of 100 RA-ILD patients who visited our tertiary care medical center between 2004 and 2011, identified those treated with an anti-TNF agent, divided patients into non-survivor and survivor groups and evaluated their clinical characteristics and causes of death. RESULTS: A total of 24 RA-ILD patients received anti-TNF therapy, of whom six died (25%). Mean age at initiation of anti-TNF therapy was significantly higher in the nonsurvivor versus survivor group (76 years [range, 66 to 85] vs. 64 years [range, 50 to 81], respectively; p = 0.043). The mean duration of anti-TNF treatment in the non-survivor group was shorter (7 months [range, 2 to 14] vs. 23 months [range, 2 to 58], respectively; p = 0.030). The duration of anti-TNF therapy in all nonsurviving patients was < 12 months. Pulmonary function test results at ILD diagnosis, and cumulative doses of disease-modifying drugs and steroids, did not differ between groups. Five of the six deaths (83%) were related to lung disease, including two diffuse alveolar hemorrhages, two cases of acute exacerbation of ILD, and one of pneumonia. The sixth patient died of septic shock following septic arthritis of the knee. CONCLUSIONS: Lung complications can occur within months of initial anti-TNF treatment in older RA-ILD patients; therefore, anti-TNF therapy should be used with caution in these patients.
Adult
;
Aged
;
Aged, 80 and over
;
Antirheumatic Agents/adverse effects/*therapeutic use
;
Arthritis, Rheumatoid/complications/diagnosis/*drug therapy/immunology/mortality
;
Female
;
Humans
;
Lung Diseases, Interstitial/diagnosis/etiology/*mortality
;
Male
;
Middle Aged
;
Republic of Korea
;
Retrospective Studies
;
Risk Assessment
;
Risk Factors
;
Tertiary Care Centers
;
Time Factors
;
Treatment Outcome
;
Tumor Necrosis Factor-alpha/*antagonists & inhibitors
10.Two Cases of Acute Interstitial Pneumonia During the Second Trimester of Pregnancy.
Ki Cheol KIL ; Gui Se Ra LEE ; Se Yeon LEE ; Jung Soo CHOI ; Hee Jung YU ; Dong Jin KWON ; Jong Chul SHIN
Korean Journal of Perinatology 2006;17(4):419-425
We present two cases of acute interstitial pneumonia (AIP) during the second trimester of pregnancy managed by mechanical ventilation, high dose corticosteroids. We described clinical course, laboratory data and imaging studies. Case 1) A 29-year-old woman, G1P1, was referred for aggravated continuous coughing, sputum and dyspnea, pleuritic chest pain and mild fever for 3 weeks at 24(+3) weeks of gestation. There were coarse breathing sounds with crackles on the both lung field. Her chest X-ray showed diffuse haziness in both lungs with suspicious nodular opacities and suggested pneumonia. HRCT showed diffuse ground glass opacities with interstitial thickening and suspicious fine nodular infiltration in both lungs suggesting acute interstitial pneumonia combined with ARDS. Because her symptoms were more aggravated, she was performed mechanical ventilation treatment. After that, she was performed cesarean hysterotomy and delivered a dead male 850grams. After her symptoms were much more improved. All antibiotics were stopped and reduced the doses of steroids, she was discharged with t-tube capped state. Case 2) A 33-year-old woman, G1P1, was referred for continuous coughing, sputum and dyspnea for 3 months and low abdominal discomfort at 24(+4) weeks of gestation. There were coarse breathing sounds with rales on the both lung field. Her chest X-ray showed diffuse haziness in both lungs with suspicious nodular opacities and suggested interstitial pneumonia. HRCT showed diffuse ground glass opacities with some intralobular and interlobular interstitial thickening and suspicious fine nodular infiltration in both lungs suggesting acute interstitial pneumonia or miliary TBc combined with ARDS. She was treated with antibiotics, oxygen, high dose corticosteroids, and tocolytics. There was no evidence of TBc in the bronchoscopy. She showed decreased mentality and decreased O2 saturation below 90% in spite of mechanical ventilation, high dose steroids and IVGV therapy. She delivered a boy of 870 g (Apgar score 1/5). After delivery, she was expired due to combined aggravating DIC. Her baby was expired at the next day, too. The outcome of AIP is fatal, reporting 59~100% mortality rate. The clinical course, laboratory data and treatment are not well established due to rarity of this disease entity. Chest X-ray and HRCT may be helpful in diagnosis and high dose steroid and immunosuppressive agents usually used but the efficacy is not guaranteed.
Adrenal Cortex Hormones
;
Adult
;
Anti-Bacterial Agents
;
Bronchoscopy
;
Chest Pain
;
Cough
;
Dacarbazine
;
Diagnosis
;
Dyspnea
;
Female
;
Fever
;
Glass
;
Humans
;
Hysterotomy
;
Immunosuppressive Agents
;
Lung
;
Lung Diseases, Interstitial*
;
Male
;
Mortality
;
Oxygen
;
Pneumonia
;
Pregnancy
;
Pregnancy Trimester, Second*
;
Pregnancy*
;
Respiration, Artificial
;
Respiratory Sounds
;
Sputum
;
Steroids
;
Thorax
;
Tocolytic Agents